AndreaBozzo/ceres-open-data-index huggingface dataset:
Dental Utilization By Provider

This dataset provides beneficiary and service counts for annual dental visits, dental preventive services, dental treatment, and dental exams by rendering providers (by NPI) for calendar year (CY) 2020.  It includes Fee-For-Service (FFS), Geographic Managed Care (GMC), and Pre-Paid Health (PHP) Plans delivery systems. Rendering providers are categorized as either rendering or rendering at a safety net clinic.  Beneficiaries are grouped by Age 0-20 and Age 21+.
Effect of a homeopathic drug, Chelidonium, in amelioration of p-DAB induced hepatocarcinogenesis in mice

Background
          Crude extracts of Chelidonium majus, and also purified compounds derived from crude extracts of this plant, have been reported to exhibit anti-viral, anti-inflammatory, anti-tumor and anti-microbial properties both in vitro and in vivo. Chelidonium is a homeopathic drug routinely used against various liver disorders including cancer in humans. Two potencies of Chelidonium (Ch-30, Ch-200) have been tested for their possible anti-tumor and enzyme modulating activities in liver and anti-clastogenic effects during p-DAB-induced hepatocarcinogenesis in mice compared to suitable controls.
        
        
          Methods
          Several cytogenetic and enzymatic protocols were used at three fixation intervals; at 60 days, 90 days and 120 days of treatment. Different sets of healthy mice were fed: i) hepatocarcinogen, p-DAB plus phenobarbital (PB), ii) only PB, iii) neither p-DAB nor PB (normal control). One set of mice fed with p-DAB plus PB was also fed Ch-30 (iv) and another set Ch-200 (v). All standard currently used methods were adopted for cytogenetical preparations and for the enzyme assays.
        
        
          Results
          All group (i) mice developed tumors in liver at all fixation intervals, while none of group (ii) and (iii) mice developed any tumors. About 40% mice in group (iv) and group (v) did not show tumor nodules in their liver. Feeding of Chelidonium to group (iv) and (v) mice reduced genotoxic effects to a significant extent (p < 0.05 to p < 0.001).
        
        
          Conclusion
          The homeopathic drug Chelidonium exhibited anti-tumor and anti-genotoxic activities and also favorably modulated activities of some marker enzymes. Microdoses of Chelidonium may be effectively used in combating liver cancer.
Compound 529973: 2-(3,4-Bis[(trimethylsilyl)oxy]phenyl)-3,5,7-tris[(trimethylsilyl)oxy]-4H-chromen-4-one

Chemical compound data from PubChem database. IUPAC Name: 2-[3,4-bis(trimethylsilyloxy)phenyl]-3,5,7-tris(trimethylsilyloxy)chromen-4-one. Molecular Formula: C30H50O7Si5. Molecular Weight: 663.1. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Harmful and Potentially Harmful Constituents

The FDA shall publish in a format that is understandable and not misleading to a lay person, and place on public display, a list of 93 harmful and potentially harmful constituents in each tobacco product and smoke established under section 904(e) of the TCA.  CTP has determined the best means to display the data is web-based on FDA.GOV.  The HPHC back-end database and template for industry will be created in a future release of eSubmissions.  The scope of this project is to: Phase 1 (Current POP): 1) build a website to support the display of the HPHC constituents, 2) allow the user to access educational information about the health effects of the chemicals; Phase 2 (next POP):  1) allow users of the website to perform a search by brand and sub-brand, 2) display a report on the HPHCs contained in that tobacco product, and 3) create an admin module to allow for an import of HPHC data via an Excel spreadsheet and to update the list of constituents.
Treatment Episode Data Set (TEDS) 1995-2005 National Admissions to Substance Abuse Treatment Services

This report presents results from the Treatment Episode Data Set (TEDS) for 2005 and trend data for 1995-2005. The report provides information on the demographic and substance abuse characteristics of the 1.8 million people admitted to treatment for abuse of alcohol and drugs in 2005 to facilities that report to individual state administrative data systems.
Primary effect of chemotherapy on the transcription profile of AIDS-related Kaposi's sarcoma

Background
          Drugs & used in anticancer chemotherapy have severe effects upon the cellular transcription and replication machinery. From in vitro studies it has become clear that these drugs can affect specific genes, as well as have an effect upon the total transcriptome.
        
        
          Methods
          Total mRNA from two skin lesions from a single AIDS-KS patient was analyzed with the SAGE (Serial Analysis of Gene Expression) technique to assess changes in the transcriptome induced by chemotherapy. SAGE libraries were constructed from material obtained 24 (KS-24) and 48 (KS-48) hrs after combination therapy with bleomycin, doxorubicin and vincristine. KS-24 and KS-48 were compared to SAGE libraries of untreated AIDS-KS, and to libraries generated from normal skin and from isolated CD4+ T-cells, using the programs USAGE and HTM. SAGE libraries were also compared with the SAGEmap database.
        
        
          Results
          In order to assess the primary response of AIDS-related Kaposi's sarcoma (AIDS-KS) to chemotherapy in vivo, we analyzed the transcriptome of AIDS-KS skin lesions from a HIV-1 seropositive patient at two time points after therapy. The mRNA profile was found to have changed dramatically within 24 hours after drug treatment. There was an almost complete absence of transcripts highly expressed in AIDS-KS, probably due to a transcription block. Analysis of KS-24 suggested that mRNA pool used in its construction originated from poly(A) binding protein (PABP) mRNP complexes, which are probably located in nuclear structures known as interchromatin granule clusters (IGCs). IGCs are known to fuse after transcription inhibition, probably affecting poly(A)+RNA distribution.
          Forty-eight hours after chemotherapy, mRNA isolated from the lesion was largely derived from infiltrating lymphocytes, confirming the transcriptional block in the AIDS-KS tissue.
        
        
          Conclusions
          These in vivo findings indicate that the effect of anti-cancer drugs is likely to be more global than up- or downregulation of specific genes, at least in this single patient with AIDS-KS. The SAGE results obtained 24 hrs after chemotherapy can be most plausibly explained by the isolation of a fraction of more stable poly(A)+RNA.
Common Pitfalls and How to Avoid Them

Through the webinar series, “Back to Basics”, the Division of State Systems within the Children’s Bureau, is offering a venue for information sharing and discussion. The fourth webinar of the series, “Common Pitfalls and How to Avoid Them”, reviews nine common pitfalls associated with building and maintaining child welfare information systems including: lack of user involvement; poorly defined requirements; scope creep, lack of a change control system, poor testing, under-allocated resources, system performance issues, lack of a high-functioning user help desk and poor vendor relationship.

Metadata-only record linking to the original dataset. Open original dataset below.
Publications Using SAMHSA Data2010 CMHS Uniform Reporting System (URS) Output Tables for Idaho

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Publications Using SAMHSA Data2022 NSDUH Companion Infographic

Review this high-level visual representation of key outcomes from the 2022 National Survey on Drug Use and Health (NSDUH). This infographic, accompanying the 2022 NSDUH National Report, covers substance use, substance use disorders, mental health issues, suicidality, and perceived recovery from substance use problems or mental health issues among the noninstitutionalized population aged 12 or older in the United States.
Child Abuse Prevention and Treatment Act Discretionary Funds Program

The discretionary fund activities funded by the Child Abuse Prevention and Treatment Act (CAPTA) support a variety of activities, including research and demonstration projects on the causes, prevention, identification, assessment and treatment of child abuse and neglect, the development and implementation of evidence-based training programs, technical assistance to grantees and communities through national resource centers and the Child Welfare Information Gateway. Grants are provided to State and local agencies and organizations as well as university- and hospital-affiliated programs. Funds have also supported contracts for cross-site evaluations, technical assistance to grantees, the biennial National Conference on Child Abuse and Neglect, various publications most notably the User Manual Series, Congressionally mandated studies, and Interagency Agreements to support multiagency efforts at the Federal level.

Metadata-only record linking to the original dataset. Open original dataset below.
Drugs to be Discontinued

Companies are required under Section 506C of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (as amended by the Food and Drug Administration Safety and Innovation Act) to notify FDA of a permanent discontinuance of certain drug products, six months in advance, or if that is not possible, as soon as practicable. These drugs include those that are life-supporting, life-sustaining or for use in the prevention or treatment of a debilitating disease or condition, including any such drug used in emergency medical care or during surgery). The discontinuations provided below reflect information received from manufacturers, and are for informational purposes only.
Compound 530640: m-Toluic acid, hex-4-yn-3-yl ester

Chemical compound data from PubChem database. IUPAC Name: hex-4-yn-3-yl 3-methylbenzoate. Molecular Formula: C14H16O2. Molecular Weight: 216.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526393: 1-Bromo,2,7,8-trichloro-dibenzo-dioxin

Chemical compound data from PubChem database. IUPAC Name: 1-bromo-2,7,8-trichlorodibenzo-p-dioxin. Molecular Formula: C12H4BrCl3O2. Molecular Weight: 366.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Head Start Impact Study (HSIS), 2002-2006

The Head Start Impact Study reports on the impacts of Head Start on children and families during the children's preschool, kindergarten, and first grade years. It was conducted with a nationally representative sample of nearly 5,000 three- and four-year old preschool children across 84 nationally representative grantee/delegate agencies in communities where there are more eligible children and families than can be served by the program.

<b>Units of Response: </b>Head Start Programs, Head Start Centers, Head Start Classroom/Teacher, Head Start Children, Head Start Families

<b>Type of Data: </b>Evaluation

<b>Tribal Data: </b>No

<b>Periodicity: </b>Irregular

<b>Demographic Indicators: </b>Disability;Ethnicity;Household Income;Race

<b>SORN: </b>https://www.federalregister.gov/documents/2015/04/02/2015-07440/privacy-act-of-1974-system-of-records-notice

<b>Data Use Agreement: </b>https://www.icpsr.umich.edu/rpxlogin

<b>Data Use Agreement Location: </b>https://www.childandfamilydataarchive.org/cfda/archives/cfda/studies/29462/datadocumentation

<b>Granularity: </b>Classroom;Individual;Program

<b>Spatial: </b>United States

<b>Geocoding: </b>Unavailable
Support for Use of Naloxone and Other Opioid Overdose Reversal Medications to Prevent Overdose Deaths

Monitoring the distribution and impact of opioid overdose reversal medications such as naloxone is essential to optimizing overdose prevention strategies and improving public health outcomes. This Statistical Data Profile, the first to use performance data from two SAMHSA grant programs, examines the distribution of FDA-approved opioid overdose reversal medications, including naloxone/Narcan. The Data Profile also presents the training of first responders, community organization staff and other individuals to administer the reversal medications and provide other support services.
Census Data - Selected socioeconomic indicators in Chicago, 2008 – 2012

This dataset contains a selection of six socioeconomic indicators of public health significance and a “hardship index,” by Chicago community area, for the years 2008 – 2012. The indicators are the percent of occupied housing units with more than one person per room (i.e., crowded housing); the percent of households living below the federal poverty level; the percent of persons in the labor force over the age of 16 years that are unemployed; the percent of persons over the age of 25 years without a high school diploma; the percent of the population under 18 or over 64 years of age (i.e., dependency); and per capita income. Indicators for Chicago as a whole are provided in the final row of the table.  See the full dataset description for more information at: https://data.cityofchicago.org/api/views/fwb8-6aw5/files/A5KBlegGR2nWI1jgP6pjJl32CTPwPbkl9KU3FxlZk-A?download=true&filename=P:\EPI\OEPHI\MATERIALS\REFERENCES\ECONOMIC_INDICATORS\Dataset_Description_socioeconomic_indicators_2012_FOR_PORTAL_ONLY.pdf
Fibroblast biology: Development and differentiation of synovial fibroblasts in arthritis

Synovial fibroblasts occur as two phenotypes - intimal and subintimal. The specialised intimal phenotype includes expression of uridine diphosphoglucose dehydrogenase (UDPGD), vascular cell adhesion molecule-1 (VCAM-1) and complement decay-accelerating factor (DAF). These gene products contribute to specialised functions relating to tissue movement and leucocyte traffic.
Behavioral Health Barometer: Washington, 2014

This is a behavioral health report for the state of Washington. It uses the  National Survey on Drug Use and Health (NSDUH) and the National Survey of Substance Abuse Treatment Services (NSSATS) to address the topics of youth substance use , youth mental health and treatment, adult mental health and treatment, substance use, substance use treatment, and medicare enrollees for the years 2009 to 2013.
Patent AT-E400617-T1: [Translated] GAMMA CRYSTAL MODIFICATION OF C.I. PIGMENT YELLOW 191 AND METHOD FOR PRODUCING IT

Phase transformation of C.I. Pigment Yellow 191 involves the effect on it, its tautomers, cis-trans isomers or cis-trans isomer tautomers of diethylene glycol dimethyl ether. Phase transformation of C.I. Pigment Yellow 191 of formula (I) involves the effect on it, its tautomers, cis-trans isomers or cis-trans isomer tautomers of diethylene glycol dimethyl ether. [Image] An independent claim is produced for the gamma modification of (I) or its isomers or tautomers, this modification optionally containing sodium or chloride ions or water molecules in its crystal lattice and having an X-ray powder diffractogram with characteristic lines. Gamma-modification is given by 2theta d/d/relative intensity values of 4.77/18.49/100; 10.08/8.67/27; 11.79/7.50/29; 13.39/6.60/20; 14.34/6.17/21; 16.71/5.30/22; 18.23/4.86/30; 21.22/4.18/29; 22.67/3.91/21;23.10/3.84/20 and 25.79/3.45/36 respectively.
Patent AT-E399742-T1: [Translated] MODIFICATION OF ALKALINE EARTH METAL SILICATE FIBERS

A method of making refractory alkaline earth silicate fibres from a melt, comprises the use as an intended component of alkali metal but not including where at least 75mol% of the alkali metal is potassium to improve the mechanical properties of the fibre in comparison with a fibre free of alkali metal.
Hospital Emergency Department - Diagnosis, Procedure, and External Cause Codes

This dataset contains statewide counts for every diagnosis, procedure, and external cause of injury/morbidity code reported on the hospital emergency department data.  Diagnosis codes are reported using ICD-9-CM or ICD-10-CM.  Procedure codes are reported using CPT-4.  External cause of injury/morbidity codes are reported using ICD-9-CM or ICD-10-CM.  ICD-10 replaced ICD-9, effective October 1, 2015.
Compound 528910: Mandelic acid, 3,4-dihydroxy, DCTFA-acetate

Chemical compound data from PubChem database. IUPAC Name: [2-acetyloxy-4-[2,2-bis[chloro(difluoro)methyl]-5-oxo-1,3-dioxolan-4-yl]phenyl] acetate. Molecular Formula: C15H10Cl2F4O7. Molecular Weight: 449.1. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Indicators of Anxiety or Depression Based on Reported Frequency of Symptoms During Last 7 Days

The U.S. Census Bureau, in collaboration with five federal agencies, launched the Household Pulse Survey to produce data on the social and economic impacts of Covid-19 on American households.  The Household Pulse Survey was designed to gauge the impact of the pandemic on employment status, consumer spending, food security, housing, education disruptions, and dimensions of physical and mental wellness.

The survey was designed to meet the goal of accurate and timely weekly estimates. It was conducted by an internet questionnaire, with invitations to participate sent by email and text message. The sample frame is the Census Bureau Master Address File Data. Housing units linked to one or more email addresses or cell phone numbers were randomly selected to participate, and one respondent from each housing unit was selected to respond for him or herself. Estimates are weighted to adjust for nonresponse and to match Census Bureau estimates of the population by age, sex, race and ethnicity, and educational attainment. All estimates shown meet the NCHS Data Presentation Standards for Proportions,
Boston: Drug-Related Emergency Department Visits, 2004-2011 - All Visits

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits in the Boston metropolitan area, covering 2004-2011. File includes all drug-related ED visits that are reportable to DAWN without regard for the reason for the visit or the specific drugs involved. It includes visits involving all forms of drug misuse or abuse plus visits resulting from adverse reaction, accidental ingestion, suicide attempts, and visits where patients were seeking detoxification services. These estimates are useful for looking at overall levels of drug involvement in ED visits.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Compound 526717: 2-(2-(2-(2-decyloxy-ethoxy)-ethoxy)-ethoxy)-ethanol, TFA

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-(2-decoxyethoxy)ethoxy]ethoxy]ethyl 2,2,2-trifluoroacetate. Molecular Formula: C20H37F3O6. Molecular Weight: 430.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529367: Met, N-isoBOC TBDMS

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] 2-(2-methylpropoxycarbonylamino)-4-methylsulfanylbutanoate. Molecular Formula: C16H33NO4SSi. Molecular Weight: 363.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401509-T1: [Translated] LINEAR MOTION GUIDE

The linear displacement guide has a guide rail (1) along which a slide (5) is displaced via rolling elements, the guide rail having a longitudinal groove (14) and spaced fixing holes, which can be concealed by a cover strip (4). This has a central section (20) and 2 clamping edges (21) engagging the opposing sidewalls (15) of the groove. An independent claim for a cover strip for a linear guide rail is also included.
Respirator Performance against Nanoparticles under Simulated Workplace Activities Data

Filtering facepiece respirators (FFRs) and elastomeric half-mask respirators (EHRs) are commonly used by workers for protection against potentially hazardous particles, including engineered nanoparticles (i.e., particles measuring less than 100 nanometers (nm). The purpose of this study was to evaluate the performance of these types of respirators against 10-400 nm particles using human subjects exposed to NaCl aerosols under simulated workplace activities. Simulated workplace protection factors (SWPFs) were measured for eight combinations of respirator models (2 N95 FFRs, 2 P100 FFRs, 2 N95 EHRs, and 2 P100 EHRs) worn by 25 healthy test subjects (13 females and 12 males) with varying face sizes. Before beginning a SWPF test for a given respirator model, each subject had to pass a quantitative fit test. Each SWPF test was performed using a protocol of six exercises for three minutes each: (i) normal breathing, (ii) deep breathing, (iii) moving head side to side, (iv) moving head up and down, (v) bending at th
National Post-acute and Long-term Care Study Residential Care Resident File

The main goals of the National Post-acute and Long-term Care Study (NPALS) are to: (1) Estimate the supply of paid, regulated long-term care services providers; (2) Estimate key policy-relevant characteristics and practices of these providers; (3) Estimate the number of long-term care services users; (4) Estimate key policy-relevant characteristics of long-term care services users; (5) Produce national and state estimates where feasible within confidentiality and reliability standards; (6) Compare across provider sectors; and (7) Monitor trends over time. 

NPALS used a two-stage probability-based sample design. In the first stage, a stratified random sample of providers were selected among RCCs; in the second stage, current services users (residents in RCCs) were randomly selected.

The provider questionnaire included survey items on provider characteristics such as ownership, size, services offered, selected practices, and staffing; questions about aggregate user characteristics (age and race) were included. The services user datasets include user demographics, health conditions, limitations with activities of daily living, number of prescription medications, adverse events, and services used. This is the services user or resident level data file. 

NPALS was previously known as the National Study of Long-Term Care Providers (NSLTCP) from 2012 to 2020.